Hovione Technology acquires rights to pulmonary inhaler

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Magicmine)
(Image: Getty/Magicmine)

Related tags: Copd, Asthma, Inhaler, Hovione Technology

Hovione Technology reaches an agreement to acquire the global rights to a reusable, cost-efficient, dry-powder inhaler.

Prior to CPhI North America, Hovione Technology stated that it will license a dry powder inhaler (DPI) design from its inventor, Klaus-Dieter Beller, and his own privately run company, Med & Tec.

The one part system is able to load and automatically pierce a single or double blister, with doses of up to 50mg supported.

According to Hovione Technology, the reusable device, to be called Papillon, is an ‘ultra-affordable’, could reduce the complexity of pulmonary devices due to it being comprised of a single part.

Hovione Technology - Papillon DPI (1)
Papillion inhaler. Image: Hovione Technology

The device can be used for chronic or acute pulmonary conditions, with Hovione Technology providing examples of potential uses in asthma or chronic obstructive pulmonary disease. It also has potential uses in the delivery of cystic fibrosis treatments, antibiotics, and anti-viral drugs.

Hovione Technology’s CEO, Peter Villax, said: “This is a strategic DPI development for Hovione Technology which emphasises our long-term commitment to offer market access to a portfolio of innovative inhalers that maximize simplicity of use, drug delivery performance and cost-effectiveness on a truly global scale. We are delighted to accelerate commercialisation of this innovative blister DPI”.

Hovione Technology will continue to develop the device in collaboration with its inventor, Beller, and is already available for licensing and supply.

Related news

Show more

Related products

show more

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars